Abstract

Insular diffuse glioma resection is at risk of vascular injury and of postoperative new neurocognitive deficits. To assess safety and efficacy of surgical management of insular diffuse gliomas. Observational, retrospective, single-institution cohort analysis (2005-2019) of 149 adult patients surgically treated for an insular diffuse glioma: transcortical awake resection with intraoperative functional mapping (awake resection subgroup, n=61), transcortical asleep resection without functional mapping (asleep resection subgroup, n=50), and stereotactic biopsy (biopsy subgroup, n=38). All cases were histopathologically assessed according to the 2016 World Health Organization classification and cIMPACT-NOW update 3. Following awake resection, 3/61 patients had permanent motor deficit, seizure control rates improved (89%vs 69% preoperatively, P=.034), and neurocognitive performance improved from 5% to 24% in tested domains, despite adjuvant oncological treatments. Resection rates were higher in the awake resection subgroup (median 94%) than in the asleep resection subgroup (median 46%; P<.001). There was more gross total resection (25%vs 12%) and less partial resection (34%vs 80%) in the awake resection subgroup than in the asleep resection subgroup (P<.001). Karnofsky Performance Status score <70(adjusted hazard ratio [aHR] 2.74, P=.031), awake resection (aHR 0.21, P=.031), isocitrate dehydrogenase (IDH)-mutant grade 2 astrocytoma (aHR 5.17, P=.003), IDH-mutant grade 3 astrocytoma (aHR 6.11, P<.001), IDH-mutant grade 4 astrocytoma (aHR 13.36, P=.008), and IDH-wild-type glioblastoma (aHR 21.84, P<.001) were independent predictors of overall survival. Awake surgery preserving the brain connectivity is safe, allows larger resections for insular diffuse gliomas than asleep resection, and positively impacts overall survival.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call